Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
38.46
Dollar change
-1.46
Percentage change
-3.66
%
Feb 06, 5:51 PMCentene posts a narrower‑than‑expected Q4 adjusted loss on better‑than‑forecast revenue and says it completed the Magellan Health asset divestiture in December with a $389M after‑tax impairment; it raised 2025 adjusted EPS guidance to $2.08 and set 2025 revenue at $186.5–$190.5B. On its Q4 call, Centene targeted 2026 adjusted EPS above $3 on $170–$174B revenue (HBR ~91%, assuming a 4.5% Medicaid rate increase) and said 2026 earnings will be highly seasonal with most EPS in Q1 and an expected Q4 loss amid Medicaid and Marketplace margin recovery.
IndexS&P 500 P/E- EPS (ttm)-13.62 Insider Own2.73% Shs Outstand491.76M Perf Week-11.22%
Market Cap18.90B Forward P/E9.05 EPS next Y4.25 Insider Trans-0.35% Shs Float478.11M Perf Month-15.97%
Enterprise Value- PEG0.19 EPS next Q2.23 Inst Own95.59% Short Float2.56% Perf Quarter4.40%
Income-6.67B P/S0.10 EPS this Y44.76% Inst Trans-3.01% Short Ratio1.74 Perf Half Y52.26%
Sales194.78B P/B0.95 EPS next Y41.14% ROA-8.33% Short Interest12.23M Perf YTD-6.54%
Book/sh40.57 P/C- EPS next 5Y46.48% ROE-28.79% 52W High66.03 -41.75% Perf Year-36.67%
Cash/sh- P/FCF4.37 EPS past 3/5Y- - ROIC-17.89% 52W Low25.08 53.38% Perf 3Y-48.82%
Dividend Est.- EV/EBITDA- Sales past 3/5Y10.45% 11.88% Gross Margin- Volatility4.83% 3.95% Perf 5Y-35.47%
Dividend TTM- EV/Sales- EPS Y/Y TTM-317.13% Oper. Margin-0.15% ATR (14)1.77 Perf 10Y23.94%
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM19.44% Profit Margin-3.43% RSI (14)32.43 Recom2.58
Dividend Gr. 3/5Y- - Current Ratio1.10 EPS Q/Q-497.29% SMA20-12.77% Beta0.51 Target Price44.27
Payout0.00% Debt/Eq0.87 Sales Q/Q21.86% SMA50-8.14% Rel Volume2.36 Prev Close39.92
Employees60500 LT Debt/Eq0.87 EarningsFeb 06 BMO SMA200-5.57% Avg Volume7.03M Price38.46
IPODec 13, 2001 Option/ShortYes / Yes EPS/Sales Surpr.2.55% 2.77% Trades Volume16,602,653 Change-3.66%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Upgrade Barclays Equal Weight → Overweight $54
Oct-14-25Initiated Goldman Sell $33
Jul-28-25Downgrade Cantor Fitzgerald Overweight → Neutral $38
Jul-23-25Downgrade Wells Fargo Overweight → Equal Weight $30
Jul-21-25Downgrade TD Cowen Buy → Hold $33
Jul-16-25Downgrade BofA Securities Neutral → Underperform $30
Jul-10-25Downgrade Morgan Stanley Overweight → Equal-Weight $33
Jul-02-25Downgrade UBS Buy → Neutral $45
Jul-02-25Downgrade JP Morgan Overweight → Neutral $48
Jun-09-25Resumed Morgan Stanley Overweight $70
Feb-06-26 05:33PM
04:28PM
04:01PM
01:49PM
01:23PM
12:35PM Loading…
12:35PM
11:58AM
11:17AM
11:00AM
10:45AM
09:30AM
07:25AM
07:13AM
06:56AM
06:56AM
06:34AM Loading…
06:34AM
06:00AM
Feb-05-26 10:59AM
10:32AM
07:10AM
Feb-04-26 10:02PM
09:41PM
06:46AM
Feb-03-26 12:36PM
03:08AM
Feb-02-26 08:54AM
08:29AM
Feb-01-26 07:47AM
Jan-31-26 07:38AM
Jan-29-26 08:30AM
02:19AM Loading…
02:19AM
Jan-28-26 12:03PM
10:31AM
08:01AM
Jan-27-26 04:44PM
04:44PM
04:34PM
04:13PM
12:55PM
12:20PM
11:15AM
10:39AM
10:35AM
10:07AM
09:55AM
08:52AM
07:17AM
07:16AM
07:15AM
03:18AM
Jan-26-26 11:35PM
10:16PM
10:16PM
Jan-22-26 08:00AM
Jan-21-26 01:29PM
Jan-20-26 09:48AM
Jan-19-26 09:33AM
07:38AM
Jan-16-26 10:47AM
Jan-15-26 03:10PM
12:04PM
08:00AM
Jan-13-26 04:30PM
05:30AM
Jan-08-26 12:21PM
Jan-07-26 08:00AM
Jan-06-26 11:04AM
07:04AM
Jan-05-26 12:16PM
11:08AM
07:15AM
Jan-01-26 11:05PM
Dec-30-25 10:16AM
Dec-29-25 08:12PM
Dec-23-25 09:08AM
Dec-22-25 11:33PM
Dec-19-25 08:45AM
Dec-17-25 03:01PM
01:00PM
10:56AM
09:10AM
07:11AM
07:11AM
Dec-16-25 04:01PM
02:10PM
03:56AM
Dec-15-25 12:35PM
Dec-12-25 03:22PM
Dec-11-25 11:35PM
03:00PM
01:08PM
11:41AM
Dec-09-25 11:33PM
Dec-04-25 07:37AM
Dec-03-25 07:51AM
Dec-02-25 09:39AM
Nov-28-25 05:30PM
11:30AM
08:50AM
Nov-26-25 11:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burdick Kenneth ADirectorDec 03 '25Sale39.0433,2111,296,557305,161Dec 05 05:06 PM
Burdick Kenneth ADirectorDec 04 '25Sale39.0032,7961,279,044272,365Dec 05 05:06 PM
Burdick Kenneth ADirectorDec 04 '25Proposed Sale39.0032,7961,279,044Dec 04 04:39 PM
Burdick Kenneth ADirectorDec 03 '25Proposed Sale39.0433,2111,296,621Dec 03 04:59 PM
Wayne S DeVeydtDirectorOct 15 '25Proposed Sale35.845,489196,737Oct 15 03:29 PM
DeVeydt Wayne SDirectorSep 09 '25Proposed Sale29.1910,775314,545Sep 09 01:55 PM
LONDON SARAHChief Executive OfficerAug 08 '25Buy25.5019,230490,365845,275Aug 11 05:28 PM
Samuels Theodore R. IIDirectorJul 28 '25Buy27.629,000248,58032,000Jul 29 06:01 PM
FASOLA KENNETH JOfficerMar 21 '25Proposed Sale59.068,500501,970Mar 21 10:37 AM